Quantitative Multiplex Immunohistochemistry Reveals Myeloid-Inflamed Tumor-Immune Complexity Associated with Poor Prognosis
Oregon Health & Science University · Intel (United States) · +4 more institutions
Abstract
Here, we describe a multiplexed immunohistochemical platform with computational image processing workflows, including image cytometry, enabling simultaneous evaluation of 12 biomarkers in one formalin-fixed paraffin-embedded tissue section. To validate this platform, we used tissue microarrays containing 38 archival head and neck squamous cell carcinomas and revealed differential immune profiles based on lymphoid and myeloid cell densities, correlating with human papilloma virus status and prognosis. Based on these results, we investigated 24 pancreatic ductal adenocarcinomas from patients who received neoadjuvant GVAX vaccination and revealed that response to therapy correlated with degree of mono-myelocytic…
Citation impact
- FWCI
- 23.35
- Percentile
- 100%
- References
- 35
Authors
22Topics & keywords
- Tissue microarray
- Immune system
- Immunohistochemistry
- Multiplex
- FOXP3
- Biomarker
- CD8
- Myeloid
Funding
- UDU.S. Department of Defense
- BCBreast Cancer Research Foundation
- LFLustgarten Foundation
- OHOregon Health and Science UniversityAward: P30 CA069533-17
- NINational Institutes of Health
- OCOregon Clinical and Translational Research InstituteAward: UL1TR000128
- NCNational Cancer InstituteAward: CA192405
- NCNational Center for Advancing Translational Sciences